MDJM released FY2024 Annual Earnings on April 14, 2025 (EST), with actual revenue of USD 48.38K and EPS of USD -189.9806
Brief Summary
In its 2024 fiscal year annual report, MDJM announced revenues of $48,400 USD, a net loss of $3,189,205 USD, and an earnings per share (EPS) of -$189.9806 USD.
Impact of The News
Analysis of MDJM’s 2024 Annual Financial Report
On April 14, 2025 (US Eastern Time), MDJM released its annual report for the 2024 fiscal year. The reported figures—revenue of approximately $48,400 against a net loss of nearly $3.19 million—indicate a period of significant financial distress for the company. The extremely low revenue suggests that the company’s core business operations generated minimal income, while the substantial loss points to high operating costs, impairments, or other expenses far exceeding its earnings.
Performance in the Context of Broader Market Indicators
While direct peer comparisons are unavailable in the provided information, contrasting MDJM’s 2024 performance with financial results from other firms in early 2026 provides a stark view of its position. It is important to note the time lag, as these benchmarks are from a period almost a year after MDJM’s report.
Contrast with High-Growth Tech:
Nvidia, for its fiscal year ending January 31, 2026, reported record-breaking revenue of $215.94 billion and a net profit of $42.96 billion, demonstrating massive growth .
Oracle also posted strong results that surpassed market expectations for its third quarter, driven by its cloud services segment .
These examples highlight a robust environment for large-cap technology companies, which is diametrically opposed to the financial state reflected in MDJM’s 2024 report.
Contrast with Companies Facing Challenges:
The beverage company ifbh, in its 2025 annual report, experienced a decline in profit despite an 11.9% increase in revenue to $176 million, illustrating a struggle with profitability .
Another company saw its profit growth slow from 45.35% in 2023 to 5.79% in 2024 .
Even these companies, which faced their own set of challenges, operated on a revenue scale that is orders of magnitude larger than MDJM’s, underscoring the severity of MDJM’s operational and financial situation in 2024.
Potential Transmission Path and Business Outlook
The transmission of this financial information would likely have the following implications:
Investor Confidence: The combination of negligible revenue and a significant multimillion-dollar loss would severely undermine investor confidence. The resulting EPS of -$189.9806 per share is a powerful negative signal that could trigger a significant sell-off in the company’s stock, leading to a sharp decline in its market capitalization.
Operational Viability: Such financial results raise critical questions about the company’s business model and its long-term viability. The market would likely anticipate that without a drastic and successful strategic overhaul—such as securing new revenue streams, aggressive cost-cutting, or a major capital injection—the company could face insolvency or delisting.
Future Outlook: Based on the 2024 data, the subsequent path for MDJM would be fraught with challenges. The company would be under immense pressure to demonstrate a clear path to profitability. Any future financial disclosures would be intensely scrutinized for signs of a turnaround. Without evidence of substantial improvement in revenue generation and cost management in subsequent quarters, the negative sentiment would likely persist, creating a difficult environment for raising capital and continuing operations.
